REQUEST A DEMO
Total
USD $0.00
Search more companies

American Generics S A S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Lessors of Nonfinancial Intangible Assets (except Copyrighted Works)
Full name: American Generics S A S Profile Updated: April 29, 2019
Buy our report for this company USD 19.99 Most recent financial data: 2018 Available in: English & Spanish Download a sample report

American Generics S A S is based in Colombia, with the head office in Cali. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. American Generics S A S was incorporated on February 08, 1994. American Generics S A S currently employs 1 (2004) people. In its most recent financial highlights, the company reported a net sales revenue increase of 470.44% in 2018. Its’ total assets recorded a growth of 1051.62%. The net profit margin of American Generics S A S increased by 13.94% in 2018.

Headquarters
Cr 1 46 84
Cali; Valle del Cauca;

Contact Details: Purchase the American Generics S A S report to view the information.

Website: http://www.americangenerics.net

Basic Information
Total Employees:
Purchase the American Generics S A S report to view the information.
Registered Capital:
Purchase the American Generics S A S report to view the information.
Ratings:
Purchase the American Generics S A S report to view the information.
Incorporation Date:
February 08, 1994
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after American Generics S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
470.44%
Total operating revenue
470.44%
Operating profit (EBIT)
1694.33%
Net Profit (Loss) for the Period
952.85%
Total assets
1051.62%
Total equity
1736.28%
Operating Profit Margin (ROS)
31.1%
Net Profit Margin
13.94%
Return on Equity (ROE)
-52.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?